Experience with intra-amniotic prostaglandin F2 alpha for abortion.
D000032:Abortion, Therapeutic; D000293:Adolescent; D000328:Adult; D000649:Amniocentesis; D000650:Amnion; D002648:Child; D003967:Diarrhea / Q000139:chemically induced; D004716:Endometritis / Q000209:etiology; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007239:Infections / Q000209:etiology; D007275:Injections, Intravenous; D010121:Oxytocin / Q000627:therapeutic use; D010298:Parity; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins; D010121:Oxytocin